High-pressure phase equilibria for the synthesis of ionic liquids in compressed CO2 for 1-hexyl-3-methylimidazolium bromide with 1-bromohexane and 1-methylimidazole

The use of carbon dioxide in the synthesis of ionic liquids (ILs) has many advantages over conventional solvents. Here, the high-pressure phase equilibria (including CO2 solubility, volume expansion, and mixture critical points) are measured and modeled for the system involved in the synthesis of a model imidazolium ionic liquid 1-hexyl-3-methylimidazolium bromide ([HMIm][Br]) from 1-bromohexane and 1-methylimidazole. The global phase behavior of 1-methylimidazole was investigated and found to be a Type V system (or potentially IV) from the classification of Scott and van Konynenburg with regions of vapor–liquid equilibrium, vapor–liquid–liquid equilibrium, liquid–liquid equilibrium, an upper and lower critical endpoint and mixture critical points. The solubility and volume expansion of CO2 in 1-methylimidazole, 1-bromohexane, a 1:1 mixture of 1-methylimidazole and 1-bromohexane and [HMIm][Br] was determined at 313.15 K and 333.15 K for pressures ranging from 10 to 160 bar. The solubility of CO2 and the volume expansion increases in the order of [HMIm][Br] ≪ 1-methylimidazole < 1:1 mixture of reactants < 1-bromohexane. The Peng–Robinson equation of state with van der Waals 2-parameter mixing rules was used with estimated critical properties to well correlate the vapor–liquid equilibrium. The results have important ramifications on the kinetics and process constraints of an actual IL synthesis with CO2.